Disclosure of interest: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2490 - ESOC25-722 ASSOCIATION BETWEEN PHYSICAL ACTIVITY AND CRYPTOGENIC ISCHEMIC STROKE IN YOUNG ADULTS: A CASE-CONTROL STUDY Shakar Kutal 1 , Jukka Putaala 1 , Pauli Ylikotila 2 , Pekka Jkl 3 , Juha Huhtakangas 4 , Petra Redfors 5 , Janika Krv 6 , Ulrike Waje-Andreassen 7 , Bettina von Sarnowski 8 , Marialuisa Zedde 9 , Kristina Ryliskiene 10 , Ana Catarina Fonseca 11 , Radim Licenik 12 , Alessandro Pezzini, Nicolas Martinez-Majander 1 1 Neurology, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland, 2 Department of Neurology, Neurocenter, Turku University Hospital, University of Turku, Turku, Finland, 3 Kuopio University Hospital, Neurocenter Neurology, Finland and University of Eastern Finland, Kuopio, Finland, 4 Department of Neurology, Neurocenter, Oulu University Hospital, Oulu, Finland and Research Unit of Clinical Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland, 5 Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden, 6 Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia, 7 Department of Neurology, Haukeland University Hospital, Bergen, Norway, 8 Department of Neurology, University Medicine Greifswald, Greifswald, Germany, 9 Neurology Unit, Azienda Unit Sanitaria Locale IRCCS di Reggio Emilia, Reggio Emilia, Italy, 10 Centre of Neurology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania, 11 Department of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria-CHLN, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal, 12 North West Anglia NHS Foundation Trust Acute Stroke Centre, Peterborough, United Kingdom Background and Aims: There is scarce data on the association of low physical activity (PA) with cryptogenic ischemic stroke (CIS), particularly among young adults with distinct PA patterns and intensities compared to elderly stroke patients
acetazolamide, acetylsalicylic acid, atenolol, azathioprine, furosemide, mycophenolic acid, ribavirin), cation-pi or ionic interactions
Rhrig et al., 2017)
Combinaciones: La L-carnitina se puede combinar con otros suplementos, como aminocidos de cadena ramificada (BCAA) o cafena, para potenciar an ms sus efectos en el rendimiento y la prdida de peso
Introducing Melt n Glo a clinically formulated, 90-second daily ritual powered by: Japanese #Glutathione (Opitac) for deep cellular detox Liposomal #VitaminC for enhanced absorption and collagen support #Lutein & #Zeaxanthin for skin protection and luminosity Melt n Glo: A 90-second daily ritual for deep skin transformation True radiance begins beneath the surface
doi: 10.1016/S0145-2126(98)00154-4 28 PaninaSBPeiJBaranNTjahjonoEPatelSAlatrashGet al
